Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world perampanel treatment in pediatric epilepsy (4–18 years)
ChiCTR2300076947Phase 4Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Sep 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in epilepsy, sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Responder rate (≥50% seizure frequency reduction). Started Sep 2023; status: recruiting.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2300076947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076947.